GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk.
Eur Heart J · 2021
Last updated 2026-05-28| Journal | Eur Heart J, 2021 |
|---|---|
| Citations | 4 |
| Relative citation ratio | 0.18 |
| NIH percentile | 12 |
| Molecules | — |
| Conditions studied | Obesity, Cardiovascular Risk Reduction |
Full record and abstract on PubMed 33822032 ↗